In September 2004, the Quigley Company, a wholly owned subsidiary of Pfizer, filed for Chapter 11 relief in the United States Bankruptcy Court for the Southern District of New York, and advised the court in its first-day filings that it intended on filing a pre-negotiated Chapter 11 plan as soon as practicable that would establish a trust and provide for channeling injunctions in favor of, among others, Pfizer, a non-debtor third party, pursuant to 11 U.S.C. ' 524.
Second Circuit Allows Asbestos Claims to Proceed Against Pfizer
An in-depth look at why and how the Second Circuit reached its decision on asbestos claims against Pfizer, whose parent company had filed for bankruptcy.
By
Steven B. Smith and Dana Gale HefterThis premium content is locked for The Bankruptcy Strategist subscribers only
ENJOY UNLIMITED ACCESS TO THE SINGLE SOURCE OF OBJECTIVE LEGAL ANALYSIS, PRACTICAL INSIGHTS, AND NEWS IN The Bankruptcy Strategist
- Stay current on the latest information, rulings, regulations, and trends
- Includes practical, must-have information on copyrights, royalties, AI, and more
- Tap into expert guidance from top entertainment lawyers and experts
Already have an account? Sign In Now
For enterprise-wide or corporate access, please contact Customer Service at [email protected] or call 1-877-256-2473.
